Blog
RSS FeedPosted by Michael Wonder on 03 Oct 2019
An unconventional health care speech: Trump wishes pharma stocks would drop, and implies drug industry is behind impeachment
3 October 2019 - President Trump is back in attack mode — and drug companies are again a clear target. ...
Posted by Michael Wonder on 03 Oct 2019
Drug firms 'colluded' to overcharge NHS by up to 1,800%
3 October 2019 - Three drug manufactures broke competition law by colluding to illegally boost the price of a vital ...
Posted by Michael Wonder on 03 Oct 2019
Pelosi's plan to slash drug prices will backfire
2 October 2019 - Yes, prescription medicine costs too much. But stealth government price-setting isn’t the answer. ...
Posted by Michael Wonder on 02 Oct 2019
Trump set to nominate Stephen Hahn as FDA commissioner, pending vetting process
1 October 2019 - President Trump is set to nominate Dr. Stephen Hahn to lead the Food and Drug Administration, ...
Posted by Michael Wonder on 02 Oct 2019
Trump administration invitation for states to design wellness programs draws swift backlash
1 October 2019 - Critics say the suggestion to tie premium costs to health goals amounts to discrimination against people with ...
Posted by Michael Wonder on 02 Oct 2019
Trump and Pelosi aides talk drug costs despite impeachment
2 October 2019 - Even as the impeachment battle rumbled, senior White House and Democratic aides sat down Tuesday to ...
Posted by Michael Wonder on 02 Oct 2019
Trump says Pelosi’s promise to work with him on drug price plan is ‘camouflage’ for impeachment
2 October 2019 - Trump is accusing Pelosi of trying to distract voters from the impeachment inquiry with promises to work ...
Posted by Michael Wonder on 02 Oct 2019
The real impact of drug price legislation on biopharmaceutical R&D
2 October 2019 - As outcry around drug prices rages, arguments continue to surface that limiting corporate revenues via price controls ...
Posted by Michael Wonder on 02 Oct 2019
Trade agreement drug monopoly is obsolete given faster, better drug discovery
2 October 2019 - For decades, the brand-name drug industry has relentlessly promoted the message that any reduction in its ...
Posted by Michael Wonder on 01 Oct 2019
Pelosi’s drug pricing plan could wipe out some key funding for low income hospitals
30 September 2019 - A 60 word provision tucked into Nancy Pelosi’s signature drug pricing plan could wreak havoc on ...
Posted by Michael Wonder on 01 Oct 2019
FDA informs patients, providers and manufacturers about potential cybersecurity vulnerabilities for connected medical devices and health care networks that use certain communication software
1 October 2019 - Today, the U.S. FDA is informing patients, health care professionals, IT staff in health care facilities and ...
Posted by Michael Wonder on 01 Oct 2019
US Food and Drug Administration review of statistical analysis of patient-reported outcomes in lung cancer clinical trials approved between January, 2008, and December, 2017
1 October 2019 - With the advent of patient-focused drug development, the US FDA has redoubled its efforts to review patient-reported ...
Posted by Michael Wonder on 30 Sep 2019
Harnessing the patient voice in real world evidence: the essential role of patient-reported outcomes
30 September 2019 - Real-world evidence is increasingly valued by regulators and payers. ...
Posted by Michael Wonder on 30 Sep 2019
Can Washington deliver on drug costs amid impeachment probe?
29 September 2019 - Major legislation to reduce prescription drug costs for millions of people may get sidelined now that House ...
Posted by Michael Wonder on 29 Sep 2019
Trump is finalising an executive order allowing imports of some prescription drugs
26 September 2019 - The White House says President Trump will issue an executive order within the next few weeks ...